AAAAAA

   
Results: 1-7 |
Results: 7
Treatment of the T98G glioblastoma cell line with antisense oligonucleotides directed toward mRNA encoding - Transforming growth factor-alpha and theepidermal growth factor receptor
Authors: Rubenstein, M Glick, R Lichtor, T Mirochnik, Y Chou, P Guinan, P
Citation: M. Rubenstein et al., Treatment of the T98G glioblastoma cell line with antisense oligonucleotides directed toward mRNA encoding - Transforming growth factor-alpha and theepidermal growth factor receptor, MED ONCOL, 18(2), 2001, pp. 121-130
Changes in radical prostatectomy and radiation therapy rates for African Americans and whites
Authors: Shaw, M Elterman, L Rubenstein, M McKiel, CF Guinan, P
Citation: M. Shaw et al., Changes in radical prostatectomy and radiation therapy rates for African Americans and whites, J NAT MED A, 92(6), 2000, pp. 281-284
The case of Peter Slade
Authors: Cohen, LS Guinan, P Harvey, P
Citation: Ls. Cohen et al., The case of Peter Slade, PSYCHOLOGIS, 12(2), 1999, pp. 65-65
In vivo establishment of T98G human glioblastoma
Authors: Rubenstein, M Shaw, M Mirochnik, Z Slobodskoy, L Glick, R Lichtor, T Chou, P Guinan, P
Citation: M. Rubenstein et al., In vivo establishment of T98G human glioblastoma, METH FIND E, 21(6), 1999, pp. 391-393
Patterns of care for metastatic carcinoma of the prostate gland: results of the American College of Surgeons' patient care evaluation study
Authors: Guinan, P Stewart, AK Fremgen, AM Menck, HR
Citation: P. Guinan et al., Patterns of care for metastatic carcinoma of the prostate gland: results of the American College of Surgeons' patient care evaluation study, PROSTATE C, 1(6), 1998, pp. 315-320
Paclitaxel is more effective than thalidomide in inhibiting LNCaP tumor growth in a prostate cancer model
Authors: Guinan, P Shaw, M Mirochnik, Y Slobodskoy, L Ray, V Rubenstein, M
Citation: P. Guinan et al., Paclitaxel is more effective than thalidomide in inhibiting LNCaP tumor growth in a prostate cancer model, METH FIND E, 20(9), 1998, pp. 739-742
Growth factor deprivation therapy of hormone insensitive prostate and breast cancers utilizing antisense oligonucleotides
Authors: Rubenstein, M Mirochnik, Y Chou, P Guinan, P
Citation: M. Rubenstein et al., Growth factor deprivation therapy of hormone insensitive prostate and breast cancers utilizing antisense oligonucleotides, METH FIND E, 20(10), 1998, pp. 825-831
Risultati: 1-7 |